AZN, NasdaqGS

AstraZeneca PLC (AZN)

Price (as of October 21)

54.97USD

Correlations

The correlation describes the statistical relationship between the value of two assets over time. Use this relationship to bet against an asset without shorting it or diversify your portfolio more effectively. Learn how you can use correlations to your advantage.

Lowest within Industry

Symbol Correlation

DERM

Journey Medical Corporation

-0.08

AKAN

Akanda Corp.

-0.06

AMYT

Amryt Pharma plc

-0.05

ACOR

Acorda Therapeutics, Inc.

-0.04

ACB

Aurora Cannabis Inc.

-0.04

AMGN

Amgen Inc.

-0.03

ENDP

Endo International plc

-0.03

DRRX

DURECT Corporation

-0.02

FLGC

Flora Growth Corp.

-0.02

ABBV

AbbVie Inc.

-0.02

Show more

Highest within Industry

Symbol Correlation

PFE

Pfizer Inc.

0.41

LLY

Eli Lilly and Company

0.4

JNJ

Johnson & Johnson

0.39

MRK

Merck & Co., Inc.

0.38

ZTS

Zoetis Inc.

0.37

BMY

Bristol-Myers Squibb Company

0.36

GILD

Gilead Sciences, Inc.

0.26

BIIB

Biogen Inc.

0.24

EMBC

Embecta Corp.

0.13

CRDL

Cardiol Therapeutics Inc.

0.07

Show more

Profile

Sector:
Healthcare
Industry:
Drug Manufacturers

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/Ondexxya, Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. The company’s marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; Seroquel IR/Seroquel XR for schizophrenia bipolar disease; Nexium, and Losec/Prilosec for gastroenterology; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity; Neurimmune AG to develop and commercialize NI006; Ionis Pharmaceuticals, Inc. to develop eplontersen, a liver-targeted antisense therapy in Phase III development for the treatment of transthyretin amyloidosis; Proteros Biostructures GmbH to jointly discover novel small molecules for the treatment of hematological cancers; Sierra Oncology, Inc. to develop and commercialize AZD5153. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.